Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) FCF Margin (2022 - 2025)

Historic FCF Margin for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to 54509.7%.

  • Cardio Diagnostics Holdings' FCF Margin fell 365673800.0% to 54509.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 37689.99%, marking a year-over-year decrease of 207804800.0%. This contributed to the annual value of 14926.54% for FY2024, which is 216854600.0% up from last year.
  • Latest data reveals that Cardio Diagnostics Holdings reported FCF Margin of 54509.7% as of Q3 2025, which was down 365673800.0% from 21273.06% recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' FCF Margin ranged from a high of 7866.87% in Q1 2024 and a low of 348309.37% during Q4 2022
  • Its 4-year average for FCF Margin is 69123.98%, with a median of 30938.23% in 2024.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 2000000000bps in 2023, then plummeted by -1416956800bps in 2025.
  • Quarter analysis of 4 years shows Cardio Diagnostics Holdings' FCF Margin stood at 348309.37% in 2022, then skyrocketed by 88bps to 41859.32% in 2023, then rose by 26bps to 30938.23% in 2024, then plummeted by -76bps to 54509.7% in 2025.
  • Its last three reported values are 54509.7% in Q3 2025, 21273.06% for Q2 2025, and 149562.55% during Q1 2025.